Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
1.093,811.096,521.100,221.091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
1.254,811.253,011.253,871.226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
1.761,111.764,271.766,881.744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
3.211,833.227,213.268,383.226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
1.474,521.479,031.481,041.466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
2.392,122.396,952.421,222.382,32
SIGA:NASDAQ
SIGA Technologies Inc
4,60 US$
0,00%
(0,00) 1D
4,65 US$
+1,09% (+0,050)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SIGA...
Açın
4,57 US$
High
4,68 US$
Low
4,57 US$
Mkt. cap
329,93 mln
Avg. vol.
814,16K
Volume
381,07K
P/E ratio
14,20
52-wk high
9,62 US$
52-wk low
4,29 US$
EPS
0,32 US$
Beta
1,05
Shares outstanding
71,64 mln
No. of employees
49
News stories
From sources across the web
Profile
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Wikipedia
About SIGA Technologies Inc
CEODiem Nguyen
Employees49
Founded28 dek 1995
Headquarters-
SectorPharmaceutical industry
Websitesiga.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
7,04 mln
81,12 mln
2,62 mln
3,79 mln
Cost of goods sold
3,62 mln
29,95 mln
8,06 mln
8,03 mln
Cost of revenue
3,62 mln
29,95 mln
8,06 mln
8,03 mln
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,68 mln
5,49 mln
4,79 mln
5,26 mln
Operating expense
5,68 mln
5,49 mln
4,79 mln
5,26 mln
Total operating expenses
9,30 mln
35,44 mln
12,84 mln
13,29 mln
Operating income
-2,26 mln
45,68 mln
-10,22 mln
-9,50 mln
Other non operating income
-
-
-
-
EBT including unusual items
-570,42K
47,27 mln
-8,36 mln
-7,96 mln
EBT excluding unusual items
-570,42K
47,27 mln
-8,36 mln
-7,96 mln
Income tax expense
-162,19K
11,79 mln
-1,99 mln
-2,53 mln
Effective tax rate
28,43%
24,94%
23,82%
31,82%
Other operating expenses
-
-
-
-
Net income
-408,22K
35,48 mln
-6,37 mln
-5,43 mln
Net profit margin
-5,80%
43,74%
-242,97%
-143,12%
Earnings per share
-
-
-
-
Interest and investment income
1,68 mln
1,59 mln
1,87 mln
1,54 mln
Interest expense
-
-
-
-
Net interest expenses
1,68 mln
1,59 mln
1,87 mln
1,54 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,12 mln
45,82 mln
-10,08 mln
-9,35 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more